phosphorylcholine has been researched along with Patency of the Ductus Arteriosus in 4 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of surfactant administration for respiratory distress syndrome (RDS) on indomethacin (INDO) pharmacodynamics and dosing requirements for patent ductus arteriosus (PDA) closure and renal toxicity was evaluated." | 1.36 | Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability. ( Carlos, RQ; Davonzo, C; Dimaguila, MA; Gal, P; McPherson, C; Ransom, JL; Smith, M; Wimmer, JE, 2010) |
| "Pulmonary hemorrhage was defined by an onset of bright red blood from the endotracheal tube in quantities that resulted in increased ventilatory support and a new infiltrate on a chest radiograph." | 1.29 | Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. ( Buck, R; Garland, J; Weinberg, M, 1994) |
| "A haemodynamically significant patent ductus arteriosus was clinically evident significantly earlier in babies who had received Survanta (mean age 1." | 1.29 | Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation. ( Malathi, I; Ng, KC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McPherson, C | 1 |
| Gal, P | 1 |
| Ransom, JL | 1 |
| Carlos, RQ | 1 |
| Dimaguila, MA | 1 |
| Smith, M | 1 |
| Davonzo, C | 1 |
| Wimmer, JE | 1 |
| Garland, J | 1 |
| Buck, R | 1 |
| Weinberg, M | 1 |
| Malathi, I | 1 |
| Ng, KC | 1 |
| Stevenson, D | 1 |
| Walther, F | 1 |
| Long, W | 1 |
| Sell, M | 1 |
| Pauly, T | 1 |
| Gong, A | 1 |
| Easa, D | 1 |
| Pramanik, A | 1 |
| LeBlanc, M | 1 |
| Anday, E | 1 |
1 trial available for phosphorylcholine and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arte | 1992 |
3 other studies available for phosphorylcholine and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Biological Products; Coho | 2010 |
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Topics: Cohort Studies; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemorrhage; Hu | 1994 |
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arte | 1995 |